Leila Mohammadi, MD, PhD

Title(s)Assistant Researcher, Medicine
SchoolSchool of Medicine
Address513 Parnassus Ave, MSB
San Francisco CA 94117
Phone415-502-7148
EmailLeila.Mohammadi@ucsf.edu
ORCID ORCID Icon0000-0001-9586-1468 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Moscow Medical Academy I.M. Sechenov, Moscow-RussiaMD06/2009General Medicine
    First Moscow State Medical Univesity I.M. Sechenov, Moscow-RussiaResidency08/2011Internal Medicine
    First Moscow State Medical University I.M. Sechenov, Moscow-RussiaPhD09/2014Cardiovascular Diseases Research
    University of California, San Francisco, San FranciscoPostdoctoral04/2021Cardiovascular Diseases Research
    Collapse Awards and Honors
    American Heart Association Postdoctoral Fellowship2019  - 2021Leila Mohammadi

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Effects of chronic cannabis use on endothelial function
    California Department of Cannabis Control Jul 1, 2021 - Jun 30, 2023
    Role: C0-Investigator
    Relative Endothelial Toxicity of Tobacco Smoke and E-Cigarette Aerosol: A Functional and Mechanistic Assessment.
    UCSF Research Allocation Program U54HL147127Jan 1, 2020 - Aug 31, 2021
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Collaboration Interests
    Collapse Faculty Mentoring

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Chronic E-Cigarette Use Impairs Endothelial Function on the Physiological and Cellular Levels. Arterioscler Thromb Vasc Biol. 2022 11; 42(11):1333-1350. Mohammadi L, Han DD, Xu F, Huang A, Derakhshandeh R, Rao P, Whitlatch A, Cheng J, Keith RJ, Hamburg NM, Ganz P, Hellman J, Schick SF, Springer ML. PMID: 36288290; PMCID: PMC9625085.
      View in: PubMed   Mentions:
    2. Comparable Impairment of Vascular Endothelial Function by a Wide Range of Electronic Nicotine Delivery Devices. Nicotine Tob Res. 2022 06 15; 24(7):1055-1062. Rao P, Han DD, Tan K, Mohammadi L, Derakhshandeh R, Navabzadeh M, Goyal N, Springer ML. PMID: 35100430; PMCID: PMC9199952.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    3. Functional Impairment of Endothelial Cells in vitro After Exposure to Serum From E-cigarette Users. 2020; (40):A522. Leila Mohammadi , Daniel Han , Ronak Derakhshandeh , Abel Huang , Adam Whitlatch , Fengyun Xu , Rachel J Keith , Naomi Hamburg , Peter Ganz , Judith Hellman , Suzaynn F Schick , Matthew L Springer . View Publication.
    4. Circulation. The Effects of Tobacco Smoking and Electronic Cigarette Use on the Level of Albuminuria and Vascular Augmentation Index in Young Healthy Population. 2019; 140(Suppl-1):A10019. Anna Bragina, Natalia Druzhinina, Leila Mohammadi, Evgenii Khvalin, Artem Dubchak, Luba Vasilyeva, Valery Podzolkov. View Publication.
    5. Modeling Cardiovascular Risks of E-Cigarettes With Human-Induced Pluripotent Stem Cell-Derived Endothelial Cells. J Am Coll Cardiol. 2019 06 04; 73(21):2722-2737. Lee WH, Ong SG, Zhou Y, Tian L, Bae HR, Baker N, Whitlatch A, Mohammadi L, Guo H, Nadeau KC, Springer ML, Schick SF, Bhatnagar A, Wu JC. PMID: 31146818; PMCID: PMC6637948.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    6. Relative endothelial toxicity of tobacco smoke and e-cigarette aerosol: A functional and mechanistic assessment. 2018. Leila Mohammadi, Ronak Derakhshande, Daniel D Han, Abel Huang, Adam Witlatch, Suzaynn F schick, Matthew L Springer. View Publication.
    7. [Progression of Atrial Fibrillation in Patients With Arterial Hypertension When Choosing Different Treatment Strategies for Arrhythmia]. Kardiologiia. 2017 Nov; 57(11):29-33. Podzolkov VI, Tarsimanova AI, Mohammadi LN. PMID: 29276915.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Predictors of progression of atrial fibrillation in patients with congestive heart failure. Predictors of progression of atrial fibrillation in patients with congestive heart failure. 2017; 7(95):613-617. Podzolkov V.I., Tarzimanova A.I., Mohammadi L. View Publication.
    9. Statins in secondary prevention of atrial fibrillation in hypertensive patients. 2017. Podzolkov, V.; Tarzimanova, A.; Pisarev, M.; Gataulin, R.; Mohammadi, L. View Publication.
    10. Changes of vascular wall rigidity and endothelial function in hypertensive patients with atrial fibrillation. 2014. Leila Mohammadi (Thesis in Russian) . . View Publication.
    11. Change in vascular wall rigidity in hypertensive patients with persistence atrial fibrillation. 2014; 3. A. Tarzimanova, Candidate of Medical Sciences; Professor V. Podzolkov, MD; L. Mokhammadi; I. Loria I.M. View Publication.
    12. [The altered endothelial function in patients with arterial hypertension and different forms of atrial fibrillation]. Klin Med (Mosk). 2014; 92(3):42-6. Podzolkov VI, Tarzimanova AI, Mokhammadi LN. PMID: 25269195.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Does treatment strategy for atrial fibrillation influence myocardial contractile function?. 2013; 9(6):619-626. Valery Podzolkov, Aida Tarzimanova , Irakli Loriya, Leila Mohammadi. . View Publication.
    14. Correlation of vascular wall stiffness with the left atrial size in hypertensive patients with atrial fibrillation. Correlation of vascular wall stiffness with the left atrial size in hypertensive patients with atrial fibrillation. 2013; 62(Suppl 1 ). Mohammadi LN, Podzolkov VI, Tarzimanova AI, Pisarev MV. View Publication.
    15. Changes of collagen III binding activity of von Willebrand factor in hypertensive patients with different forms of atrial fibrillation. Changes of collagen III binding activity of von Willebrand factor in hypertensive patients with different forms of atrial fibrillation. 2013; 34(suppl_1):5604. Mohammadi L, Tarzimanova A, Podzolkov V, Pisarev M, Loriya I . View Publication.
    16. Effects of Propafenone on Myocardial Inotropic Function in Patients with Hypertension and Atrial Fibrillation. Effects of Propafenone on Myocardial Inotropic Function in Patients with Hypertension and Atrial Fibrillation. 2012; 6(74):19-23. Tarzimanova A.I., Podzolkov V.I., Loriya I. Zh., Mokhammadi L.N. View Publication.
    17. Comparing the changes in cardiac rhythm turbulence in 2 groups of patients diagnosed with IHD group 1 suffer from Atrial Fibrillation, Group 2 not suffer from Atrial Fibrillation. 2010. Mohammadi L, Podzolkov VI, Matveev VV, Abramova AA.
    18. Cardiac Rhabdomyoma in fetus with Tuberous sclerosis. 2009. Mohammadi L, Kogan E.
    Leila's Networks
    Concepts (38)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (3)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.1.0-878-g44689f21 on PROFILES-PWEB03.

    Copyright © The Regents of the University of California